Bioavailability studies ensure generic drugs work like brand-name versions by measuring how much and how fast the active ingredient enters the bloodstream. The FDA uses strict pharmacokinetic standards to approve generics safely and affordably.
Read More
Tamoxifen and SSRIs can interact by reducing endoxifen levels, but large studies show no clear link to worse breast cancer outcomes. Learn which antidepressants are safest and what experts recommend now.
Read More
Generic drugs save money but increase the risk of pharmacy errors due to differences in appearance, manufacturers, and labeling. Learn how pharmacists can prevent and correct these mistakes to protect patient safety.
Read More
Generic drug prices vary wildly between U.S. states due to secret PBM practices, weak state laws, and lack of competition. Paying cash often beats insurance. Here's why and what you can do.
Read More
Learn how to navigate insurance rules around generic drug substitution, when you can insist on brand-name meds, and how to fight back if a switch affects your health. Know your rights and save money without risking your treatment.
Read More
Proton pump inhibitors can drastically reduce the absorption of key antifungals like itraconazole and ketoconazole, leading to treatment failure. Fluconazole is unaffected by stomach pH but interacts with blood thinners. New research shows PPIs may also boost antifungal power-creating a complex clinical paradox.
Read More
Combining SSRIs and opioids like tramadol can trigger serotonin syndrome - a potentially fatal condition. Learn which drug pairs are dangerous, how to spot early symptoms, and safer alternatives for pain and depression management.
Read More
Generic drugs saved $482 billion in the U.S. in 2024 alone, making up 90% of prescriptions but just 12% of spending. Learn how they cut costs, the role of biosimilars, and why brand-name drugs still dominate spending.
Read More
Generic drugs save billions but raise safety questions. Learn the truth about bioequivalence, rare risks for narrow therapeutic index drugs, and how to protect yourself when switching from brand-name to generic medications.
Read More
The EU's generic drug market is shaped by four approval pathways, complex bioequivalence rules, and major 2025 reforms that are speeding up market entry. Learn how regulators, manufacturers, and patients are affected.
Read More
